Summary of Recent Changes
Significant changes to this guidance include the following:
These guidelines have evolved as a result of greater experience with COVID-19, the availability of published data on COVID-19, continued evidence of community transmission of COVID-19 including asymptomatic and pre-symptomatic transmission of more infectious variants, established infection control principles, and the availability of effective COVID-19 vaccines.
In addition to following these HCP guidelines, HCF are required to follow State and Local Health Officer Orders and All Facilities Letters (AFLs) including health care worker vaccination requirements and return to work for exposed and infected HCP:
They are also expected to follow CDC and Cal/OSHA COVID-19 infection prevention guidance and requirements including universal use of PPE for patient care, use of N95 respirators for the care of suspect or confirmed COVID-19 cases, and routine respirator fit testing.
Employers and facilities can have policies that are stricter than those required by State and County Health Officer Orders and Cal/OSHA or recommended by the CDC.
CDC, CDPH, and LAC DPH urge everyone to remain up to date with COVID-19 vaccination, including the most recent booster dose to protect themselves and reduce the spread of the virus. See CDC Stay Up to Date with COVID-19 Vaccines Including Boosters for more information. Visit LAC DPH Vaccine Schedule website for easy-to-read color schedules in English and Spanish.
Health Care Worker Vaccine Requirement
All persons who work in healthcare facilities must complete a primary COVID-19 vaccine series and receive a single booster dose as required by the California and the LA County Public Health Officers.
Workers who are already in compliance with the vaccine requirement (i.e., completed a primary series and received a single booster) are not required to stay up to date with recommended COVID-19 boosters. The bivalent booster is, however, strongly recommended.
Workers who are newly coming into compliance with the State and Local healthcare worker vaccine requirements must receive their booster dose within 15 days after becoming eligible. HCP who have completed their primary series who provide proof of subsequent COVID-19 infection may defer this booster administration for up to 90 days after infection. The 90 days are from the onset of the initial COVID-19 symptoms. If they never had symptoms, then the 90 days are from the date of collection of the first positive viral COVID-19 test.
Workers may be exempt from the vaccination requirements based on either a) Religious Beliefs or b) a Qualifying Medical Reason.
For details, please refer to the orders and related resources:
HCP with higher risk occupational exposures and those with close contact exposures outside of work (community exposures) may continue to work, regardless of vaccination status, as long as they do not develop symptoms or test positive for SARS-CoV-2. Serial post-exposure testing is required. HCF should follow the table below to guide the management of asymptomatic HCP with exposures based upon the facility staffing level.
All HCP with exposures should wear an N95 respirator at all times while in the facility until they have a negative test result on Day 5.Table 1. Management of Asymptomatic HCP with Exposures
|Vaccination Status||Routine||Critical Staffing Shortage|
|All HCP, regardless of vaccination status||No work restriction with negative diagnostic test† upon identification (but not earlier than 24 hours after exposure) and if negative, test at days 3 and 5.||No work restriction with diagnostic test† upon identification (but not earlier than 24 hours after exposure) and at days 3 and 5.^|
†Either an antigen test or nucleic acid amplification test (NAAT) can be used. In general, post exposure testing of asymptomatic HCP who have recovered from SARS-CoV-2 infection in the prior 30 days is not recommended. If the exposed HCP’s first positive prior test was 31-90 days ago, then antigen testing is recommended.
^ If most recent test is positive, see Table 2 Work Restrictions for HCP with SARS-CoV-2 Infection.
Higher-risk occupational exposure
In the healthcare setting, the following exposures to a confirmed infectious COVID-19 case* are considered high-risk:
*COVID-19 cases are considered to be infectious beginning 2 days prior to symptom onset (or initial positive viral test if case is asymptomatic) until the time they meet criteria for discontinuing isolation.
HCP who are close contacts in the community are considered higher risk. This is because at work, HCP must follow infection control prevention and control procedures and they use personal protective equipment (PPE) per strict standards. To see the definition of a close contact in the community, see CDPH Guidance on Isolation and Quarantine of the General Public.
For more information, see the CDPH AFL:
Symptomatic persons Regardless of vaccination status, HCP with any signs or symptoms of COVID-19 should be prioritized for SARS-CoV-2 viral testing (and other respiratory viral testing, such as influenza, as indicated), even if the symptoms are mild.
HCP with SARS-CoV-2 infection Testing is required for return to work prior to completing the 10-day isolation. See Table 2. Work Restrictions for HCP with SARS-CoV-2 Infection (Isolation).
Post-exposure Testing is required for asymptomatic HCP after a high-risk occupational or community close-contact exposure to SARS-CoV-2 as outlined in Table 1. Management of Asymptomatic HCP with Exposures. Testing also should be performed in response to a cluster of cases meeting the outbreak investigation threshold for hospitals in AFL 20-75.
Screening of asymptomatic HCP is no longer routinely recommended except in outbreak investigations. During periods of high community transmission of COVID-19, LAC DPH may recommend this practice.
HCP with symptoms of COVID-19 should be excluded from work pending SARS-CoV-2 diagnostic testing.
For HCP who were initially suspected of having COVID-19 but, following evaluation, another diagnosis is suspected or confirmed, return-to-work decisions should be based on their other suspected or confirmed diagnoses.
See CDC Interim Guidance for Managing HCP with SARS-CoV-2 Infection.
|Vaccination Status||Routine||Critical Staffing Shortage|
|All HCP, regardless of vaccination status||5 days* with
at least one negative diagnostic test† same day or within 24 hours prior to return OR
10 days without a viral test
|<5 days with most recent diagnostic test† result to prioritize staff placement‡|
*Asymptomatic or mildly symptomatic with improving symptoms and meeting negative test criteria; facilities should refer to CDC guidance for HCP with severe to critical illness or moderately to severely immunocompromised.
† Either an antigen test or nucleic acid amplification test (NAAT) can be used. Some people may be beyond the period of expected infectiousness but remain NAAT positive for an extended period. Antigen tests typically have a more rapid turnaround time but are often less sensitive than NAAT. Antigen testing is preferred for discontinuation of isolation and return-to-work for SARS-CoV-2 infected HCP and for HCP who have recovered from SARS-CoV-2 infection in the prior 90 days; NAAT is also acceptable if done and negative within 48h of return.
‡ If most recent test is positive, then HCP may provide direct care only for patients/residents with confirmed SARS-CoV-2 infection, preferably in a cohort setting. This may not apply for staff types or in settings where practically infeasible (e.g., Emergency Departments where patient COVID status is unknown) or where doing so would disrupt safe nurse to patient ratios, and for staff who do not have direct patient/resident care roles. The HCP must maintain separation from other HCP as much as possible (for example, use a separate breakroom and restroom) and wear a N95 respirator for source control at all times while in the facility until at least 10 days from symptoms onset or positive test (for HCP who remain asymptomatic throughout their infection).
HCP returning to work between days 5-9 after meeting routine criteria should wear a fit-tested N95 for source control through at least Day 10 from symptoms onset or positive test (for HCP who remain asymptomatic throughout their infection).
In addition, healthcare facilities should make N95 respirators available to any HCP who wishes to wear one when not otherwise required for the care of patients or residents with suspected or confirmed COVID-19.
Return to Work Practices and Work Restrictions
If you have questions, email LAC DPH at email@example.com or call at 213-240-7941.